01.11.25 -- Clinical Leader Best Of December

Looking ahead to 2025, Clinical Leader seeks to understand how clinical research professionals are incorporating AI into their work. So we asked them, “Simply put: Are you using any iteration of AI in your role within clinical research? If so, how and why?”

Is it any surprise that when I asked a group of clinical trial industry experts to summarize some of the things that stood out to them in 2024, that AI would be mentioned more than once? Probably not. Resistance to DCTs, increasing regulatory scrutiny, and a slowdown in CRO M&As also made their lists — but I’m guessing none of that surprises you, either.

We've overcomplicated site selection, says Stryde Research CEO Chintan Desai. Here, Desai details what qualities sponsors should look for in sites and why some of our existing criteria aren't cutting it.

AI revolutionizes clinical trials by optimizing study design, automating processes, enhancing patient-centric approaches, and providing real-time insights.

As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.

Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.